Tazobactam prevention of emergence of resistance.
作者信息
Neu H C, Niu W W, Chin N X
机构信息
Department of Medicine, Columbia University, New York, New York 10032.
出版信息
Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):477-80. doi: 10.1016/0732-8893(89)90081-3.
PMID:2560419
Abstract
摘要
相似文献
1
Tazobactam prevention of emergence of resistance.他唑巴坦预防耐药性的出现。
Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):477-80. doi: 10.1016/0732-8893(89)90081-3.
2
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).哌拉西林与β-内酰胺酶抑制剂他唑巴坦（YTR 830）联合应用的体外比较活性
Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):481-8. doi: 10.1016/0732-8893(89)90082-5.
3
Susceptibility survey of piperacillin alone and in the presence of tazobactam.单独使用哌拉西林以及在有他唑巴坦存在的情况下的药敏试验。
J Antimicrob Chemother. 1993 Jan;31 Suppl A:23-8. doi: 10.1093/jac/31.suppl_a.23.
4
5
Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
Zentralbl Bakteriol. 1991 Oct;275(4):500-3. doi: 10.1016/s0934-8840(11)80171-4.
6
Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria.哌拉西林单独及与他唑巴坦联合应用对产β-内酰胺酶细菌的抗菌活性。
J Formos Med Assoc. 1991 Oct;90(10):947-52.
7
High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospital.在一家希腊医院分离出的大肠杆菌和肺炎克雷伯菌菌株中，对哌拉西林/他唑巴坦的耐药率很高。
Diagn Microbiol Infect Dis. 1997 Sep;29(1):39-41. doi: 10.1016/s0732-8893(97)00081-3.
8
In vitro and in vivo efficacy of YTR-830H and piperacillin combinations versus beta-lactamase-producing bacteria.YTR-830H与哌拉西林联合用药对产β-内酰胺酶细菌的体外和体内疗效
J Chemother. 1989 Jun;1(3):155-61. doi: 10.1080/1120009x.1989.11738884.
9
Turbidimetric and microscopic analysis of Bacteroides fragilis exposed to tazobactam and piperacillin alone and in combination.对单独及联合使用他唑巴坦和哌拉西林的脆弱拟杆菌进行比浊法和显微镜分析。
Chemotherapy. 1990;36(3):215-21. doi: 10.1159/000238769.
10
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.哌拉西林-他唑巴坦对产超广谱β-内酰胺酶大肠埃希菌和克雷伯菌属的CLSI药敏折点的临床相关性
Antimicrob Agents Chemother. 2006 Jun;50(6):2244-7. doi: 10.1128/AAC.00381-05.
引用本文的文献
1
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.哌拉西林/他唑巴坦：抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1994 Mar;47(3):506-35. doi: 10.2165/00003495-199447030-00008.
Zotero 插件